Pharmacology Fundamentals Flashcards
7 cards from real COKO practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Pharmacology Fundamentals flashcards as text
A kinesiologist notices a client taking a beta-blocker reports an unusually low resting heart rate. Which pharmacodynamic concept explains this effect?
Answer: Antagonism at beta-adrenergic receptors
Beta-blockers act as antagonists at beta-adrenergic receptors, reducing heart rate by blocking sympathetic stimulation.
Which term describes the concentration of a drug required to produce 50% of its maximum possible effect?
Answer: EC50
EC50 (effective concentration 50%) is the drug concentration producing half of the maximal response.
A client on warfarin begins taking a new NSAID. The kinesiologist should be aware that this combination may increase risk of:
Answer: Bleeding
NSAIDs can displace warfarin from plasma proteins and inhibit platelet aggregation, significantly increasing bleeding risk.
Which phase of pharmacokinetics involves the conversion of a drug to more water-soluble metabolites primarily in the liver?
Answer: Metabolism
Metabolism (biotransformation), mainly hepatic, converts lipophilic drugs into more polar metabolites for easier elimination.
A client using a corticosteroid inhaler for asthma asks about systemic side effects. Which effect is most relevant for exercise programming?
Answer: Muscle weakness and reduced bone density
Long-term corticosteroid use can cause myopathy and osteoporosis, directly affecting exercise capacity and fracture risk.
Which route of drug administration provides 100% bioavailability by bypassing first-pass metabolism?
Answer: Intravenous
Intravenous administration delivers the drug directly into systemic circulation, ensuring complete (100%) bioavailability.
A kinesiologist's client takes metformin for type 2 diabetes. During prolonged exercise, which concern is most pharmacologically relevant?
Answer: Hypoglycemia risk is lower than with insulin secretagogues
Metformin lowers blood glucose without stimulating insulin release, so hypoglycemia risk during exercise is lower compared to sulfonylureas or insulin.